A diagnosis of Kaposi sarcoma is a significant life event, but it is a manageable condition. Because KS is so closely linked to immune function, your treatment will likely involve a collaborative ...

Uterine cancer develops in the tissues of the uterus, the hollow organ in the pelvis where a fetus could grow and develop during pregnancy. There are two main types of uterine cancer. The most common ...

Synovial sarcoma, a rare cancer, thrives on glutamine. Blocking its nutrient supply with the drug V9302 stops tumor growth, offering a new way to treat the disease.

Soft tissue sarcomas are a rare group of cancers that develop in soft tissue. They can develop almost anywhere in your body, including in your hip, thigh, and groin. Soft tissue sarcomas are rare ...

Sarcomas are tumors that form in the body’s connective tissues such as bone, muscle and fat. They are rare and, because there are more than 150 types, patients benefit from seeing a sarcoma specialist ...

Soft tissue sarcomas are cancers that develop in your body’s soft tissues like muscle, fat, tendons, or cartilage. Your legs are the most common place they develop. The American Cancer Society ...

Synovial sarcoma is an aggressive malignant tumor that primarily affects the limbs of teenagers and young adults. While it can be cured if completely removed by surgery, recurrence or metastasis, the ...

Carrie Madormo, RN, MPH, is a health writer. She has over a decade of experience as a registered nurse, practicing in a variety of fields, such as pediatrics, oncology, chronic pain, and public health ...

“Onion skin,” which doctors call lamellated periosteal reaction, occurs when multiple layers of bone form in a concentric circle around the outer surface of the bone. It can occur with Ewing sarcoma.

SARC has today launched a new resource for patients and caregivers, helping to facilitate access to expert sarcoma programs for more accurate, timely, and informed diagnoses and treatments for rare ...

A recent study has answered the long-standing question of why improvements in survival outcomes for young people with cancerous soft tissue tumors have lagged behind those of their pediatric and older ...